ARCHIVES

Kadcyla Extends Median PFS In Open-Label Phase III Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

NCAB Urges $2 Tax On Cigarettes To Reduce Smoking

February 12, 1993

Fluoride Study Update Finds No Increased Risk

October 19, 1990

Afatinib Delays Tumor Growth In LUX-Head and Neck 1 Study

October 31, 2014

St. Jude Children’s Research Hospital Wins NCI Designation As Comprehensive.

May 16, 2008

In Brief: NIH Budget Cut Being Considered, Threatening NCI’s Plan For Reaching Year 2000 Goals

December 13, 1984

Only 10% Of Breast Cancer Patients May Benefit From Contralateral Mastectomy

March 26, 2010